MX9603885A - Incremento de los niveles de hemoglobina fetal usando esteres carboxilicos. - Google Patents
Incremento de los niveles de hemoglobina fetal usando esteres carboxilicos.Info
- Publication number
- MX9603885A MX9603885A MX9603885A MX9603885A MX9603885A MX 9603885 A MX9603885 A MX 9603885A MX 9603885 A MX9603885 A MX 9603885A MX 9603885 A MX9603885 A MX 9603885A MX 9603885 A MX9603885 A MX 9603885A
- Authority
- MX
- Mexico
- Prior art keywords
- aryl
- hbf
- alkyl
- fetal hemoglobin
- increasing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/206,690 US5569675A (en) | 1994-03-07 | 1994-03-07 | Methods of using carboxylic acid esters to increase fetal-hemoglobin levels |
PCT/US1995/002769 WO1995024189A1 (en) | 1994-03-07 | 1995-03-06 | Increasing fetal hemoglobin levels using carboxylic esters |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9603885A true MX9603885A (es) | 1997-05-31 |
Family
ID=22767519
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9603885A MX9603885A (es) | 1994-03-07 | 1995-03-06 | Incremento de los niveles de hemoglobina fetal usando esteres carboxilicos. |
Country Status (11)
Country | Link |
---|---|
US (1) | US5569675A (pt) |
EP (1) | EP0793488A1 (pt) |
JP (1) | JPH09510202A (pt) |
KR (1) | KR970701540A (pt) |
CN (1) | CN1148338A (pt) |
AU (1) | AU1980695A (pt) |
BR (1) | BR9507010A (pt) |
CA (1) | CA2184695A1 (pt) |
IL (1) | IL112896A0 (pt) |
MX (1) | MX9603885A (pt) |
WO (1) | WO1995024189A1 (pt) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5880152A (en) * | 1995-10-06 | 1999-03-09 | Vertex Pharmaceuticals, Inc. | Butyrate prodrugs derived from lactic acid |
US5883123A (en) * | 1995-10-06 | 1999-03-16 | Vertex Pharmaceuticals, Inc. | Butyrate prodrugs derived from lactic acid |
US5912269A (en) * | 1996-04-30 | 1999-06-15 | Vertex Pharmaceuticals, Inc. | Butyrate prodrugs derived from lactic acid |
US5827544A (en) * | 1995-10-10 | 1998-10-27 | The Arab Pharmaceutical Manufacturing Co. Ltd. | Different way of management of neonatal hyperbilirubinemia |
US5763488A (en) * | 1995-10-30 | 1998-06-09 | Vertex Pharmaceuticals Incorporated | Methods and compositions using butyrate esters of threitol |
CN1109545C (zh) * | 1996-12-13 | 2003-05-28 | 科学与工业研究会 | 螯合铁的制剂及其制备方法 |
US6130248A (en) * | 1996-12-30 | 2000-10-10 | Bar-Ilan University | Tricarboxylic acid-containing oxyalkyl esters and uses thereof |
US6110955A (en) * | 1997-03-11 | 2000-08-29 | Beacon Laboratories, Inc. | Metabolically stabilized oxyalkylene esters and uses thereof |
US6124495A (en) * | 1997-03-11 | 2000-09-26 | Beacon Laboratories, Inc. | Unsaturated oxyalkylene esters and uses thereof |
US6110970A (en) * | 1997-03-11 | 2000-08-29 | Beacon Laboratories, Inc. | Nitrogen-containing oxyalkylene esters and uses thereof |
US6030961A (en) * | 1997-03-11 | 2000-02-29 | Bar-Ilan Research & Development Co., Ltd. | Oxyalkylene phosphate compounds and uses thereof |
US5939455A (en) * | 1997-03-11 | 1999-08-17 | Beacon Laboratories, Inc. | Therapeutic augmentation of oxyalkylene diesters and butyric acid derivatives |
US6043389A (en) | 1997-03-11 | 2000-03-28 | Mor Research Applications, Ltd. | Hydroxy and ether-containing oxyalkylene esters and uses thereof |
US6822267B1 (en) * | 1997-08-20 | 2004-11-23 | Advantest Corporation | Signal transmission circuit, CMOS semiconductor device, and circuit board |
US6225350B1 (en) | 1998-03-10 | 2001-05-01 | Vertex Pharmaceuticals, Inc. | Butyrate prodrugs derived from lactic acid |
US20030162833A1 (en) | 2001-08-01 | 2003-08-28 | Roe Charles R. | Fatty acid treatment for cardiac patients |
IL144645A0 (en) * | 1999-02-05 | 2002-05-23 | Baylor University Medical Ct | Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid |
US6693132B2 (en) * | 2000-12-21 | 2004-02-17 | Beacon Laboratories, Inc. | Methods for using alkanoyloxymethyl esters |
US6720445B2 (en) | 2000-12-21 | 2004-04-13 | Beacon Laboratories, Inc. | Acetyloxymethyl esters and methods for using the same |
ITTO20020684A1 (it) * | 2002-07-31 | 2004-02-01 | Associazione Veneta Per La Lotta Alla Talassemia | Nuovo uso dell'angelicina e di suoi analoghi strutturali. |
US7154002B1 (en) | 2002-10-08 | 2006-12-26 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
EP1608628A2 (en) | 2003-03-17 | 2005-12-28 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
WO2005011696A1 (en) * | 2003-08-01 | 2005-02-10 | Fibrogen, Inc. | Inhibitors of 2-oxoglutarate dioxygenase as gamma globin inducers |
JP2008524246A (ja) | 2004-12-16 | 2008-07-10 | タケダ サン ディエゴ インコーポレイテッド | ヒストンデアセチラーゼ阻害剤 |
WO2006122319A2 (en) | 2005-05-11 | 2006-11-16 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
EA200800321A1 (ru) | 2005-07-14 | 2008-06-30 | Такеда Сан Диего, Инк. | Ингибиторы гистондеацетилазы |
US20070185045A1 (en) * | 2006-02-06 | 2007-08-09 | Ratcliffe Peter J | Inhibitors of 2-oxoglutarate dioxygenase as gamma globin inducers |
JP2009536659A (ja) | 2006-05-09 | 2009-10-15 | ヘマクエスト・ファーマシューティカルズ,インコーポレーテッド | 血液疾患の治療法 |
US9095565B2 (en) * | 2006-05-09 | 2015-08-04 | Phoenicia Biosciences, Inc. | Methods for treating blood disorders |
WO2007140335A2 (en) * | 2006-05-25 | 2007-12-06 | The Regents Of The University Of Michigan | Screening methods and transgenic animals for treatment of beta-globin related diseases and conditions |
US20110015168A1 (en) * | 2007-01-19 | 2011-01-20 | Mitchell Keegan | Methods for increasing levels of human fetal hemoglobin |
EP2641906B1 (en) | 2009-07-08 | 2015-04-22 | Dermira (Canada), Inc. | Tofa analogs useful in treating dermatological disorders or conditions |
US9713602B1 (en) * | 2016-03-15 | 2017-07-25 | National Sun Yat-Sen University | Method for facilitating the oxygen release of hemoglobin-based blood substitutes |
US11179379B2 (en) | 2017-01-30 | 2021-11-23 | The Children's Hospital Of Philadelphia | Compositions and methods for hemoglobin production |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5025029A (en) * | 1986-10-10 | 1991-06-18 | Children's Hospital Medical Center Of Northern California | Method for augmenting fetal hemoglobin |
US4822821A (en) * | 1986-10-10 | 1989-04-18 | Children's Hospital Medical Center Of Northern California | Method for augmenting fetal hemoglobin |
EP0302349B1 (en) * | 1987-07-30 | 1993-09-29 | Bar Ilan University | Biologically active carboxylic acid esters |
US5216004A (en) * | 1990-09-13 | 1993-06-01 | Children's Hospital Medical Center Of North California | Method for preventing malaria |
US5439939A (en) * | 1992-03-17 | 1995-08-08 | Children's Hospital Medical Center Of Northern California | Pharmaceutical compositions and methods using isobutyramide for treating betaglobin disorders |
EP0727989A4 (en) * | 1993-11-10 | 1998-08-19 | Sloan Kettering Inst Cancer | BUTTERIC ACID ESTERS AS CELL DIFFERENTIATING ACTIVE SUBSTANCES |
-
1994
- 1994-03-07 US US08/206,690 patent/US5569675A/en not_active Expired - Fee Related
-
1995
- 1995-03-06 CA CA002184695A patent/CA2184695A1/en not_active Abandoned
- 1995-03-06 KR KR1019960704912A patent/KR970701540A/ko not_active Application Discontinuation
- 1995-03-06 IL IL11289695A patent/IL112896A0/xx unknown
- 1995-03-06 JP JP7523569A patent/JPH09510202A/ja active Pending
- 1995-03-06 CN CN95192966A patent/CN1148338A/zh active Pending
- 1995-03-06 WO PCT/US1995/002769 patent/WO1995024189A1/en not_active Application Discontinuation
- 1995-03-06 AU AU19806/95A patent/AU1980695A/en not_active Abandoned
- 1995-03-06 BR BR9507010A patent/BR9507010A/pt not_active Application Discontinuation
- 1995-03-06 EP EP95912749A patent/EP0793488A1/en not_active Withdrawn
- 1995-03-06 MX MX9603885A patent/MX9603885A/es unknown
Also Published As
Publication number | Publication date |
---|---|
CA2184695A1 (en) | 1995-09-14 |
EP0793488A1 (en) | 1997-09-10 |
US5569675A (en) | 1996-10-29 |
CN1148338A (zh) | 1997-04-23 |
KR970701540A (ko) | 1997-04-12 |
WO1995024189A1 (en) | 1995-09-14 |
AU1980695A (en) | 1995-09-25 |
BR9507010A (pt) | 1997-09-16 |
IL112896A0 (en) | 1995-06-29 |
EP0793488A4 (pt) | 1997-09-10 |
JPH09510202A (ja) | 1997-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9603885A (es) | Incremento de los niveles de hemoglobina fetal usando esteres carboxilicos. | |
ZA9410084B (en) | Methods of inhibiting thrombin | |
IL111288A (en) | Uses of 2-phenyl-3-aroylbenzothiophenes and 3-phenyl-4-aroyl-1,2-dihydronaphthalenes for the preparation of a medicament for inhibiting smooth muscle cell proliferation and restinosis | |
PT651999E (pt) | Metodos de inibicao da fibrose uterina | |
HUT75111A (en) | Use of pyridyl-,oxadiazole or thiadiazole derivatives for producing pharmaceutical compositions having effect | |
DE69426855T2 (de) | Verwendung von 2-phenyl-3-aroylbenzothiophen Derivaten zur Herstellung eines Medikaments zur Hemmung des Knorpelabbaus | |
DE69125216D1 (de) | Aminoalkanesulfonsäurederivate und pharmazeutische Zusammensetzungen davon zur Prävention oder Behandlung von Herzerkrankungen | |
DE69209128D1 (de) | Verwendung von Indazol-Methoxyalkansäure zur Herstellung eines Arzneimittels zur Behandlung von Autoimmunkrankheiten | |
CA2118425A1 (en) | Benzothiazolesulfonamide derivative, Method for Preparing the Same, and Use Thereof | |
IL88740A0 (en) | Compositions for the inhibition of viruses | |
ES8507468A1 (es) | Procedimiento de obtencion de agentes de beta-bloqueantes conteniendo grupos ester con propiedades oftalmologicas | |
GR900300046T1 (en) | Oxabicycloheptane derivatives, pharmaceutical composition and use | |
ZA842769B (en) | 2-n-cycloalkylmethyl 3-oxo 5,6-diaryl as-triazines their method of production and their use as medicament | |
IL126795A0 (en) | Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders | |
ATE94050T1 (de) | Mittel zur verhinderung von zahnbelagbildung. | |
LV11524A (lv) | Benzidamina izmantosana TNF izsaukto patologisko stavoklu arstesana | |
WO2001035938A3 (de) | Pharmakologisch aktive tetrahydrothiopyran-4-ol-derivate, verfahren zu ihrer herstellung und verwendung | |
JPS6419019A (en) | Antiamnestic agent | |
BG103985A (en) | Multicyclic derivatives of erythromycin | |
DE69109933D1 (de) | Verwendung von Mizoribin zur Behandlung oder Vorbeugung der Multiplen Sklerose. | |
MX9703611A (es) | Uso de bis-arilfuranos en la preparacion de composiciones para la inhibicion de neumonia por pneumocystis carinii, giardia lamblia y criptosporidium parvum. | |
TH18631B (th) | วิธีการยับยั้งธรอมบิน | |
MX9702853A (es) | Metodos para inhibir condiciones asociadas con el neuropeptido "y". | |
NZ336321A (en) | Use of benzothiophene (raloxifene) for treating breast cancer | |
EP0810201A4 (en) | PREVENTIVE / HEALING AGENT FOR LIVER DISEASES |